Ellsworth Advisors »

Pacira Pharmaceuticals shares owned by Ellsworth Advisors

Quarter-by-quarter ownership of Pacira Pharmaceuticals (PCRX) shares owned by Ellsworth Advisors from 13F filings

Historical chart of Ellsworth Advisors investment in Pacira Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Pacira Pharmaceuticals held by Ellsworth Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Pacira Pharmaceuticals by Ellsworth Advisors

Quarter filed Position value Share count Share price at filing
2026-09-30 $1.1M 44k 25.05

More positions owned by Ellsworth Advisors

Harbor Etf Trust Comm All Wea Etf (HGER)
NVIDIA Corporation (NVDA)
Spdr Gold Tr Gold Shs (GLD)
First Tr Exchange-traded First Tr Enh New (FTSM)
Microsoft Corporation (MSFT)
Apple (AAPL)
Johnson & Johnson (JNJ)
Advanced Micro Devices (AMD)
Broadcom (AVGO)
Eaton Corp SHS (ETN)
Alphabet Cap Stk Cl C (GOOG)
Chevron Corporation (CVX)
Cisco Systems (CSCO)
Enterprise Products Partners (EPD)
Amgen (AMGN)

View all positions for Ellsworth Advisors

Top funds holding Pacira Pharmaceuticals

BlackRock
Doma Perpetual Capital Management
Vanguard Portfolio Management
Dimensional Fund Advisors
D. E. Shaw & Co
Renaissance Technologies
Vanguard Capital Management
Goldman Sachs Group
Geode Capital Management
American Century Companies
UBS Group
Impax Asset Management Group
Two Sigma Investments
Charles Schwab Investment Management
Sixth Street Partners Management Company

View all funds holding Pacira Pharmaceuticals